Regulatory approval

Japan Approves MRD Testing. Price Will Decide Whether Patients Can Use It.

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.

Triglycerides are back in the spotlight. Europe is reviewing Sobi’s olezarsen for severe risk.

Europe’s next stroke bet: can Factor XIa inhibition change prevention without raising bleeding risk?

Mental Health Patients Need Care, Not Surveillance

Cholesterol prevention is moving earlier. Is Europe ready to treat inherited risk before adulthood?

Colon Cancer Immunotherapy Moves Into the Adjuvant Access Test

AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits

Screwworm Turns Pet Treatment Into a One Health Preparedness Issue
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
